We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M Turnover 23.21%
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$240M
AUM Growth
+$31.8M
Cap. Flow
+$17.7M
Cap. Flow %
7.4%
Top 10 Hldgs %
80.41%
Holding
94
New
15
Increased
22
Reduced
3
Closed
4
Avg Time Held
2 years
Top 10 Avg Time Held
1.7 years
Top 20 Avg Time Held
1.1 years

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.06M
2
HHH icon
Howard Hughes
HHH
+$1.86M
3
DAL icon
Delta Air Lines
DAL
+$1.2M
4
DD icon
DuPont de Nemours
DD
+$1.13M
5
AB icon
AllianceBernstein
AB
+$1.08M

Top Sells

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$715K
2
ATCO
Atlas Corp.
ATCO
+$693K
3
HTZ icon
Hertz Global Holdings, Inc.
HTZ
+$495K
4
IIPR icon
Innovative Industrial Properties
IIPR
+$427K
5
MBAI icon
MBody AI Ltd. Ordinary Share
MBAI
+$349K

Sector Composition

Rank Sector Weight
1 Healthcare 73.39%
2 Financials 8.14%
3 Technology 3.76%
4 Real Estate 3.58%
5 Industrials 2.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
JNJ icon
26
Johnson & Johnson
JNJ
$616B
$963K 0.4%
7,280
– –
2013 Q2
16 quarters
CNQ icon
27
Canadian Natural Resources
CNQ
$111B
$933K 0.39%
+66,059
New +$994K
2017 Q2
0 quarters
ENFC
28
DELISTED
Entegra Financial Corp.
ENFC
$916K 0.38%
40,250
– –
2014 Q4
10 quarters
ACAD icon
29
Acadia Pharmaceuticals
ACAD
$3.29B
$863K 0.36%
30,947
-24,000
-44% -$715K
2016 Q1
5 quarters
T icon
30
AT&T
T
$161B
$832K 0.35%
29,194
+26,480
+976% +$781K
2014 Q2
12 quarters
FF icon
31
Future Fuel
FF
$245M
$827K 0.35%
54,804
– –
2013 Q2
16 quarters
VZ icon
32
Verizon
VZ
$186B
$818K 0.34%
18,311
+16,728
+1,057% +$779K
2014 Q2
12 quarters
APO icon
33
Apollo Global Management
APO
$65.4B
$794K 0.33%
+30,000
New +$799K
2017 Q2
0 quarters
RHP icon
34
Ryman Hospitality Properties
RHP
$8.69B
$794K 0.33%
12,400
+12,000
+3,000% +$765K
2013 Q2
16 quarters
GE icon
35
GE Aerospace
GE
$326B
$775K 0.32%
5,984
+5,007
+512% +$686K
2013 Q2
16 quarters
GILD icon
36
Gilead Sciences
GILD
$194B
$738K 0.31%
10,420
+3,700
+55% +$246K
2015 Q4
6 quarters
SVC
37
Service Properties Trust
SVC
$796M
$729K 0.3%
5,000
+4,800
+2,400% +$733K
2015 Q1
9 quarters
SGYP
38
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$705K 0.29%
158,400
– –
2015 Q2
8 quarters
WHLRD icon
39
Wheeler Real Estate Investment Trust Series D Preferred Stock
WHLRD
$692K 0.29%
30,000
– –
2016 Q3
3 quarters
XRN icon
40
Chiron Real Estate Inc
XRN
$402M
$688K 0.29%
15,400
– –
2016 Q2
4 quarters
WY icon
41
Weyerhaeuser
WY
$14.1B
$670K 0.28%
+20,000
New +$673K
2017 Q2
0 quarters
IBM icon
42
IBM
IBM
$219B
$659K 0.28%
4,481
– –
2015 Q1
9 quarters
CORV
43
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$608K 0.25%
134,578
+58,278
+76% +$211K
2017 Q1
1 quarter
SBCP
44
DELISTED
Sunshine Bancorp, Inc
SBCP
$593K 0.25%
27,800
– –
2014 Q3
11 quarters
IMMU
45
DELISTED
Immunomedics Inc
IMMU
$581K 0.24%
65,783
+20,283
+45% +$142K
2017 Q1
1 quarter
EW icon
46
Edwards Lifesciences
EW
$49.9B
$578K 0.24%
+14,673
New +$536K
2017 Q2
0 quarters
DERM icon
47
DELISTED
Dermira, Inc.
DERM
$537K 0.22%
+18,431
New +$560K
2017 Q2
0 quarters
CDOR
48
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$535K 0.22%
50,000
– –
2017 Q1
1 quarter
CHEKW icon
49
DELISTED
Check-Cap Ltd. Series A Warrant
CHEKW
$495K 0.21%
66,059
– –
2015 Q1
9 quarters
IRT icon
50
Independence Realty Trust
IRT
$3.48B
$494K 0.21%
50,000
– –
2016 Q4
2 quarters
1
2
3 4

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q2 2017 Portfolio in Review

As of Q2 2017, David M. Knott held 94 positions worth $240M, up 15% from $208M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

David M. Knott deployed $17.7M of net new capital in Q2 2017, opening 15 new positions and adding to 22 existing holdings. Its largest new stake was Howard Hughes: 15,735 shares worth $1.84M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 75% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Acadia Pharmaceuticals, an estimated $715K trimmed.

  • David M. Knott's largest Q2 2017 buy was Howard Hughes: 15,735 shares worth $1.84M.
  • David M. Knott added most to Pfizer in Q2 2017, an estimated $2.06M increase.
  • David M. Knott's biggest Q2 2017 reduction was Acadia Pharmaceuticals, cutting an estimated $715K.
  • David M. Knott fully exited Atlas Corp. in Q2 2017, selling an estimated $693K.
  • David M. Knott's ten largest holdings make up 80% of its $240M portfolio in Q2 2017.
  • David M. Knott opened 15 new positions and closed 4 in Q2 2017.
  • David M. Knott's portfolio value rose 15% quarter-over-quarter to $240M.

Based on David M. Knott's 13F filing for Q2 2017, filed 11 Aug 2017.